We determined whether site of care explains a previously identified racial disparity in carotid artery imaging.
Racial disparities in health care are widely reported. 1 Commonly cited mechanisms for disparities include unequal access to care, association of race with vulnerable socioeconomic characteristics, and the quality of interaction and communication between clinicians and patients. A mechanism that is receiving further attention is the site of care. [2] [3] [4] Black patients receive care from a concentrated set of hospitals. 5, 6 If those hospitals deliver a lower quality of care, then population-level disparities would be detected, even if no disparity exists within a hospital.
Carotid artery stenosis is an important, modifiable risk factor for stroke. 7, 8 Carotid artery stenosis is detected by carotid artery imaging, and therefore these diagnostic tests are routinely performed in the workup of patients presenting with ischemic stroke.
In a recent analysis, we unexpectedly found that black veterans hospitalized with ischemic stroke were less likely than white patients to receive carotid artery imaging. 9 Several explanations are cited why carotid interventions occur less commonly among black patients. However, these reasons do not address why there would be disparities of diagnostic tests to detect carotid stenosis. 10, 11 Carotid artery imaging would seem to be driven by provider behavior or system characteristics instead of patient behavior. In a prior Veterans Health Administration (VA) study, minority-serving hospitals were less likely (44% vs 74%, p Ͻ 0.001) to have MRI availability during a study period of 1996 -2002. 6 Therefore, we analyzed whether site of care could be a mechanism for the observed racial disparities in receipt of carotid artery imaging in the VA.
METHODS Sample. In 2009, the VA Offices of Quality and Performance (OQP), Patient Care Services (PCS), and the Stroke QUERI collaborated to conduct the Office of Quality and Performance Stroke Special Study. 12 The design of this study is a retrospective cohort of veterans admitted to all 127 Veterans Affairs Medical Centers (VAMCs) in fiscal year (FY) 2007 (October 1, 2006 1, , to September 30, 2007 with a primary discharge diagnosis of ischemic stroke. A sample of 5,000 patients was identified using all patients at low-volume facilities (Յ55 patients with ischemic stroke in FY2007) and an 80% sample of patients at high-volume facilities (Ͼ55 patients with ischemic stroke in FY2007).
Trained nurses at the West Virginia Medical Institute (WVMI) conducted chart reviews for this project. This organization has been conducting large-scale chart reviews of the VA for the past decade. For over 10 years, all VA Medical Centers have used an enterprise-wide electronic health care record system, thus allowing the WVMI to remotely retrieve and review care delivered in the VA from a central location. The nurses confirmed a hospitalization of ischemic stroke in 3,987 patients, then proceeded with a chart review of 307 data elements among the confirmed patients. Inter-rater reliability was greater than 70% for over 90% of data elements.
Exclusion criteria.
Patients were excluded if they were transferred from a non-VA hospital because carotid artery imaging performed at a non-VA hospital may not be documented in the VA medical records (figure 1). Patients were also excluded if clinicians documented a reason why carotid artery imaging was not performed or if patients refused the test. Patients were excluded if they died in the hospital, if there was documentation that they wanted less aggressive care, or if there was an indication of poor health status that may make a person ineligible for carotid interventions (Charlson comorbidity greater than 4, dementia, not ambulatory prior to admission, deemed not to be a surgical candidate). Although these extensive criteria may have excluded some patients who should have received carotid imag-ing, the goal was to identify a final sample for whom there is little doubt that carotid artery imaging should have been performed.
Race of the patient was obtained from various sources in the medical record, chiefly from the Functional Status and Outcomes Database 13 and the Centers for Medicare and Medicaid Services (CMS) Vital Status File. We excluded veterans if they were not of white or black race, because the numbers of veterans in other race categories were too few to compare across racial groups. After applying exclusion criteria, there were 1,534 white and 628 black patients in the sample, for a total of 2,162 patients.
Dependent variable.
Our dependent variable was receipt of carotid artery imaging from 12 months prior to the date of admission to 2 months after the date of admission. Even though many clinicians would repeat carotid imaging after a stroke, the length of the preadmission time period was chosen because the degree of stenosis of the carotid artery is not expected to change significantly over 12 months. The postadmission time period was chosen because carotid procedures may have a greater impact on risk reduction if done within the first 8 weeks poststroke. 14 Carotid imaging tests could consist of any of the following: carotid artery ultrasound, magnetic resonance angiography (MRA) of the neck, CT angiography (CTA) of the neck, and catheter angiography. 15 Independent variables. The 2 independent variables of interest were race of the patient and minority-serving status of the hospital. For the latter variable, the proportion of stroke patients in the study sample who were black in each hospital was calculated. While all VA hospitals treat minority patients, for purposes of this study, minority-serving hospitals were defined as the top 10th percentile of hospitals by proportion of stroke patients who were black. 3 Patient-level characteristics included age and sex. Clinical history included prior history of stroke, TIA, carotid procedures, and atrial fibrillation. The NIH Stroke Scale score, a measure of clinical stroke severity, was derived based upon review of the documented neurologic examination upon admission. 16 The Charlson score, a measure of comorbidity, was calculated for each patient. 17 Hospital-level characteristics included the annual number of stroke patients, urban/rural status, and complexity level (a VA composite measure of patient volume, comorbidity of the patient population, teaching hospital status, and intensive care unit capability). 18 Analysis. We conducted bivariate comparisons of receipt of carotid artery imaging and other characteristics between white and black patients using t tests and Wilcoxon tests for continuous measures and 2 and Fisher exact tests for categorical measures. We then conducted bivariate comparisons of receipt of carotid artery imaging, patient characteristics, and hospital characteristics between patients seen at non-minority-serving and minority-serving hospitals using these same statistical tests. We fit a series of logistic regression models which first included indicators for patient race, minority-serving status of the hospital, and an interaction term of those 2 variables. We then added patient-level characteristics that were significantly associated with carotid imaging as well as hospital characteristics. 3 Models were fit using generalized estimating equations with an exchangeable covariance structure to incorporate the correlation of imaging for patients from the same hospital. 19 Predictive margins were used to calculate predictive probabilities and risk differences. 20 The 95% confidence intervals (CIs) for probabilities and differences were obtained by fitting the models to 5,000 bootstrap samples, which we selected by randomly selecting hospitals with replacement. Analyses were conducted using SAS for Windows version 9.1 (SAS Institute, Cary, NC) and Stata/SE 10 (StataCorp LP, College Station, TX).
As a sensitivity analysis of the designation of minorityserving hospitals, we redefined it as the top 25th percentile instead of the top 10th percentile of all hospitals. 3 A second sensitivity analysis was run on a broader sample that dropped the exclusion criteria of do not resuscitate/do not intubate status, dementia, high Charlson score, and ambulation status. A third sensitivity analysis redefined the dependent variable as receipt of carotid artery imaging in the 1-week time period after presentation for acute ischemic stroke because early recurrence of stroke can occur. 21 Standard protocol approvals, registrations, and patient consents. All data were stored at the Richard L. Roudebush VA Medical Center, Indianapolis, IN. The Institutional Review Board at that facility approved the research protocol, including a waiver of consent.
RESULTS
The final sample consisted of 1,534 white patients and 628 black patients (table 1) . The unadjusted racial disparity in carotid artery imaging was 7.2% (88.6% of white patients vs 81.4% of black patients, p Ͻ 0.001). Use of ultrasound was more common among white patients (60.4% vs 41.9%, p Ͻ 0.001), while use of MRA was less common (32.9% vs 39.6%, p ϭ 0.002). Black patients were more likely to be younger than age 55, have had a prior stroke, and to have had a more severe stroke (table 1). Black patients had similar Charlson scores but a longer length of stay.
The concentration of black patients by site of care is demonstrated in table 2. Among the 114 nonminority-serving hospitals, the median proportion of black patients in each was 9.6%, whereas the 13 minority-serving hospitals had a median proportion of black patients in each hospital of 57.1% ( p Ͻ 0.001). About 40% of black patients in the entire sample were admitted to 1 of the 13 minority-serving hospitals. Patients admitted to non-minority-serving hospitals were more likely to receive carotid artery imaging than patients admitted to minority-serving hospitals (88.6% vs 77.7%, p Ͻ 0.001), and this disparity appeared to be driven by a differential use of carotid ultrasound (60.4% vs 39.6%, p Ͻ 0.001). In logistic models which accounted for clustering, minority-serving status of a hospital ( p ϭ 0.04) and patient race ( p ϭ 0.07) had similar levels of association with carotid artery imaging ( However, the predicted probabilities among white patients (78.0% [68.3%, 87.8%]) and black patients (70.5% [59.3%, 81.6%]) at minority-serving hospitals were both significantly lower ( p Ͻ 0.001) than white patients at non-minority-serving hospitals (figure 2). In post hoc analyses using black patients at minority-serving hospitals as the reference group, the 3 other groups had significantly higher use of carotid artery imaging ( p Ͻ 0.01, table e-2).
Similar results were found in sensitivity analyses defining minority-serving hospitals as the top 25% of hospitals by proportion of black patients and in analyses using the larger sample (n ϭ 2,792 patients) constructed using fewer exclusion criteria than originally applied to the sample (table e-3). When receipt of carotid imaging was limited to the week after presentation, we found a similar disparity by race (table 1) and site of care (table 2) . Of the patients who did receive carotid artery imaging, 94% did so in the first week after presentation. In multivariate models, receipt of carotid imaging among white patients at non-minority-serving hospitals was again significantly higher than white patients and black patients at minority-serving hospitals. DISCUSSION In our study, we showed that black patients were less likely than white patients to receive carotid artery imaging. We also showed that black patients receive their care at different facilities from white patients. At these predominantly minorityserving facilities, both racial groups were less likely to receive carotid artery imaging compared to white patients at non-minority-serving facilities. The overall use of carotid artery imaging in this 2007 study has improved from prior VA studies completed a decade earlier, 10, 22 but this improvement in overall carotid imaging is now accompanied by a racial disparity that was not detected in prior VA studies. Non-VA studies also have not consistently detected racial disparities in carotid artery imaging, [23] [24] [25] though studies have also reported that men consistently receive carotid artery imaging about 5%-10% higher than women. 26 -29 The use of carotid imaging among black patients and within minority-serving hospitals in our study actually appears to be as high or higher than in other studies, but the use of carotid imaging among white patients and within non-minority-serving hospitals were still significantly higher.
Although disparities in other stroke processes and outcomes of care have been well-documented, 30, 31 commonly cited explanations for disparities do not readily apply to carotid artery imaging. First, access to care is unlikely to be the cause because all patients in the sample are hospitalized. In addition, all patients in this sample have health insurance coverage for services rendered by the VA system. Second, these disparities are unlikely to be due to differential perceived risk of carotid artery imaging, as may be the case for carotid endarterectomy. 11 The most com-mon methods of imaging the carotid arteries, carotid ultrasound and MRA, are essentially risk-free and do not require informed consent. Third, these disparities are unlikely due to issues with clinician-patient interaction, such as cultural competency or shared decision-making. A study of over 300,000 patients receiving care showed considerable racial disparities for processes that require substantial interaction (such as smoking cessation) but much smaller disparities for processes that require little interaction between patient and clinician (such as prescription of ␤-blockers upon discharge). 2 Carotid artery imaging also involves very little interaction and is typically ordered by the clinician with little to no patient input. Finally, in the VA, the impact of financial incentives and barriers are greatly mitigated, which is a commonly cited reason why disparities are reduced (though not completely eliminated). 32 Therefore, other mechanisms likely underlie disparities in carotid artery imaging, although it is not readily apparent why site of care has such a strong association with disparities.
We expected that racial disparities could be driven by differential access to more advanced technology, such as MRA and CTA, but our findings were driven by differential use of carotid ultrasound, an older, more inexpensive, and more universally available technology. We do not know the reasons for this, but we note that a study of Medicare recipients also noted that black patients were significantly less likely to receive carotid ultrasound than white patients but significantly more likely to receive MRA than white patients. 23 Several limitations should be mentioned. Our definition of minority-serving hospital was based on the proportion of patients who were black, regardless of the number. 3 A prior VA study defined minority-serving hospital according to the top decile of number of black patients instead of proportion. 6 However, 9 of the 13 hospitals defined as minority-serving in our study would have also been defined as minority-serving hospital according to the alternative definition. Second, we did not have information on the specialty of the providers managing the veterans in our study. An older study determined that involvement of neurologists was associated with carotid artery imaging among persons with TIA. 33 Third, we could not determine which patients had strokes in the posterior circulation, which could not arise from embolism from the carotid artery. Two prior studies of carotid imaging did include data about the location of stroke. One study found no association between anterior vs posterior circulation and receipt of carotid artery imaging. 29 The other study found that anterior circulation location was a predictor of receipt of carotid artery imaging, though it was no longer so when the sample was restricted to patients who were eligible for surgery. 28 In our study, a substantial proportion of patients received MRA or CTA, and these tests assess both the carotid and vertebral arteries. Finally, VA users are predominantly male and have low socioeconomic status, high levels of comorbidity, and high levels of disability, 34 so results may not be generalizable to the non-VA population.
A strength of the study is the number of hospitals included in the sample. Most prior studies were conducted at too few sites to assess whether site of care is a mechanism for disparities.
Site of care should be explored as an explanation of disparities by race or ethnicity if the comparison groups are obtaining medical care from different facilities. In our study, black veterans are concentrated within a few VA hospitals. Both white patients and black patients at minority-serving hospitals were a vulnerable group with regard to the receipt of carotid artery imaging. The omission of carotid artery imaging in a patient with a new ischemic stroke represents poor quality of care because eligibility for more aggressive treatment options is not ascertained. Further investigations will focus on specific sites of care instead of the national VA system to understand the barriers to performing this clinically important diagnostic test in a hospital system that has the resources to provide access to care for its patients. 
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